Back to mobile site

U.S. HHS Issues Additional Amendment to Emergent BioSolutions' (EBS) Proposal for Anthrax rPA Vaccine

April 23, 2009 10:36 AM EDT Send to a Friend
Emergent BioSolutions Inc. (NYSE: EBS) announced today that the U.S. Department of Health and Human Services issued an additional amendment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login